The 49 references in paper V. Borovitsky S., В. Боровицкий С. (2014) “Туберкулез с широкой лекарственной устойчивостью микобактерий и ВИЧ-инфекция // Multi-drug resistant tuberculosis and HIV-infection” / spz:neicon:pulmonology:y:2013:i:2:p:109-113

1
Рекомендации по лечению резистентных форм туберкулеза. Пер. с англ. Женева: ВОЗ; 1998.
(check this in PDF content)
2
Migliori G.B., Besozzi G., Girardi E. et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur. Respir. J. 2007; 30 (4): 623–626.
(check this in PDF content)
3
Dheda K., Warren R. M., Zumla A. et al.Extensively drugresistant tuberculosis: epidemiology and management challenges. Infect. Dis. Clin. N. Am. 2010; 24 (3): 705–725.
(check this in PDF content)
4
Zwolska Z., Augustynowicz+Kopec E. Drug resistant tuberculosis. Pol. Merkur. Lekarski 2011; 30 (179): 362–366.
(check this in PDF content)
5
Martinson N.A., Chaisson R.E. Survival in XDR TB: shifting the curve and shifting the paradigm. J. Acquir. Immune Defic. Syndr. 2011; 57 (2): 89–91.
(check this in PDF content)
6
Gandhi N.R., Nunn P., Dheda K. et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010; 375 (9728): 1830–1843.
(check this in PDF content)
7
Badoum G., Saleri N., Dembele M.S. et al.Failing a re-treatment regimen does not predict MDR / XDR tuberculosis: is "blind" treatment dangerous? Eur. Respir. J. 2011; 37 (5): 1283–1285.
(check this in PDF content)
8
Chakroborty A.Drug-resistant tuberculosis: an insurmountable epidemic? Inflammopharmacology 2011; 19 (3): 131–137.
(check this in PDF content)
9
Loddenkemper R., Hauer B.Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge. Dtsch. Arztebl. Int. 2010; 107 (1–2): 10–19.
(check this in PDF content)
10
Migliori G.B, Dheda K., Centis R. et al.Review of multidrug–resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa. Trop. Med. Int. Hlth 2010; 15 (9): 1052–1066.
(check this in PDF content)
11
Prasad R. Revised National Tuberculosis Control Programme: current scenario. J. Indian Med. Assoc. 2009; 107 (10): 725–727.
(check this in PDF content)
12
Small P.M. Tuberculosis: a new vision for the 21st century. Kekkaku 2009; 84 (11): 721–726.
(check this in PDF content)
13
Mukherjee A., Lodha R., Kabra S. K. Changing trends in childhood tuberculosis. Indian J. Pediatr. 2011; 78 (3): 328–333.
(check this in PDF content)
14
Karim K.Tuberculosis and infection control. Br. J. Nurs. 2011; 20 (17): 1128, 1130–1133.
(check this in PDF content)
15
Carvalho A.C., Migliori G.B., Cirillo D.M. Tuberculosis in Europe: a problem of drug resistance or much more? Exp. Rev. Respir. Med. 2010; 4 (2): 189–200.
(check this in PDF content)
16
Fears R., Kaufmann S., Ter Meulen V. et al. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Tuberculosis (Edinb.) 2010; 90 (3): 182–187.
(check this in PDF content)
17
Matteelli A., Richardson M. D., Sotgiu G. et al. Multidrugand extensively drug-resistant TB in persons living with HIV. Exp. Rev. Respir. Med. 2009; 3 (3): 245–254.
(check this in PDF content)
18
Monedero I., Caminero J.A. MDR-/XDR-TB management: what it was, current standards and what is ahead. Exp. Rev. Respir. Med. 2009; 3 (2): 133–145.
(check this in PDF content)
19
Symons G., Shean K., Pietersen E. et al. A historical review of XDR tuberculosis in the Western Cape province of South Africa. S. Afr. Med. J. 2011; 101 (9): 636–638.
(check this in PDF content)
20
Calver A. D., Falmer A. A., Murray M. et al.Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence/ South Africa. Emerg. Infect. Dis. 2010; 16 (2): 264–271.
(check this in PDF content)
21
Kvasnovsky C. L, Cegielski J. P., Erasmus R. et al. Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients. J. Acquir. Immune Defic. Syndr. 2011; 57 (2): 146–152.
(check this in PDF content)
22
Dheda K., Shean K., Zumla A. et al. Early treatment outcomes and HIV status of patients with extensively drugresistant tuberculosis in South Africa: a retrospective cohort study. Lancet 2010; 375 (9728): 1798–1807.
(check this in PDF content)
23
Vella V., Racalbuto V., Guerra R. et al.Household contact investigation of multidrug-resistant and extensively drugresistant tuberculosis in a high HIV prevalence setting. Int. J. Tuberc. Lung Dis. 2011; 15 (9): 1170–1175.
(check this in PDF content)
24
Andrews J.R., Shah N.S., Weissman D. et al. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. PLoS One 2010; 5 (12): 15735.
(check this in PDF content)
25
Heysell S.K., Thomas T.A., Gandhi N.R. et al.Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study. BMC Infect. Dis. 2010; 10: 344.
(check this in PDF content)
26
Gandhi N.R., Shah N.S., Andrews J.R. et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am. J. Respir. Crit. Care Med. 2010; 181 (1): 80–86.
(check this in PDF content)
27
Cox H.S., McDermid C., Azevedo V. et al.Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS One 2010; 5 (11): 13901.
(check this in PDF content)
28
Thomas T.A., Shenoi S.V., Heysell S.K. et al.Extensively drug-resistant tuberculosis in children with human immunodeficiency virus in rural South Africa. Int. J. Tuberc. Lung Dis. 2010; 14 (10): 1244–1251.
(check this in PDF content)
29
Heysell S.K, Moll A.P., Gandhi N.R. et al.Extensively drugresistant Mycobacterium tuberculosis from aspirates, Rural South Africa. Emerg. Infect. Dis. 2010; 16 (3): 557–560.
(check this in PDF content)
30
Plas H., Mendelson M. High prevalence of comorbidity and need for up-referral among inpatients at a district-level hospital with specialist tuberculosis services in South Africa: the need for specialist support. S. Afr. Med. J. 2011; 101 (8): 529–532.
(check this in PDF content)
31
Moodley P., Shah N. S., Tayob N. et al.Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa. PLoS One 2011; 6 (5): 17513.
(check this in PDF content)
32
Lopes T., Gomes C., Diogo N.Tuberculosis unit: case study of 10 years of activity (1999–2009). Rev. Port. Pneumol. 2011; 17 (6): 266–271.
(check this in PDF content)
33
Rajasekaran S., Chandrasekar C., Mahilmaran A. et al. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients – a trend. J. Indian Med. Assoc. 2009; 107 (5): 281–282, 284–286.
(check this in PDF content)
34
Chakraborty N., De C., Bhattacharyya S. et al.Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in eastern India. Trans. Roy. Soc. Trop. Med. Hyg. 2010; 104 (3): 195–201.
(check this in PDF content)
35
Balaji V., Daley P., Anand A.A. et al.Risk factors for MDR and XDR-TB in a tertiary referral hospital in India. PLoS One 2010; 5 (3): 9527.
(check this in PDF content)
36
Masjedi M.R., Tabarsi P., Baghaei P. et al. Extensively drugresistant tuberculosis treatment outcome in Iran: a case series of seven patients. Int. J. Infect. Dis. 2010; 14 (5): 399–402.
(check this in PDF content)
37
Tabarsi P., Chitsaz E., Baghaei P. et al. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran. Microb. Drug Resist. 2010; 16 (1): 81–86.
(check this in PDF content)
38
Tang S., Zhang Q., Yu J. et al. Extensively drug-resistant tuberculosis at a tuberculosis specialist hospital in Shanghai, China: clinical characteristics and treatment outcomes. Scand. J. Infect. Dis. 2011; 43 (4): 280–285.
(check this in PDF content)
39
Jarand J., Shean K., O'Donnell M. et al.Extensively drugresistant tuberculosis (XDR-TB) among health care workers in South Africa. Trop. Med. Int. Hlth. 2010; 15 (10): 1179–1184.
(check this in PDF content)
40
O'Donnell M.R., Jarand J., Loveday M. et al. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers. Ann. Intern. Med. 2010; 153 (8): 516–522.
(check this in PDF content)
41
LoBue P.Extensively drug-resistant tuberculosis. Curr. Opin. Infect. Dis. 2009; 22 (2): 167–173.
(check this in PDF content)
42
Lawn S.D., Wood R. Antiretroviral therapy for control of the HIV-associated MDR and XDR tuberculosis epidemic in South Africa. Am. J. Respir. Crit. Care Med. 2010; 182 (12): 1567; author reply 1568–1569.
(check this in PDF content)
43
Amaral L., Molnar J. Therapy Of XDR TB with thioridazine a drug beyond patent protection but eligible for patent "as new use". Recent Pat. Antiinfect. Drug Discov. 2010; 5 (2): 109–114.
(check this in PDF content)
44
Huang Q., He R., Kozikowski A. P. Stereochemistry at the forefront in the design and discovery of novel anti-tuberculosis agents. Curr. Top. Med. Chem. 2011; 11 (7): 810–818.
(check this in PDF content)
45
Pieroni M., Tipparaju S.K., Lun S. et al. Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively DrugResistant (XDR) TB. ChemMedChem. 2011; 6 (2): 334–342.
(check this in PDF content)
46
Bakal R.L., Gattani S.G.Identification and development of 2,5-disubstituted oxadiazole as potential candidate for treatment of XDR and MDR tuberculosis. Eur. J. Med. Chem. 2012; 47 (1): 278–282.
(check this in PDF content)
47
Cole S.T., Riccardi G. New tuberculosis drugs on the horizon. Curr. Opin. Microbiol. 2011; 14 (5): 570–576.
(check this in PDF content)
48
Igarashi M., Takahashi Y.Developmental status of new antituberculous drugs. Nihon Rinsho 2011; 69 (8): 1482–1488.
(check this in PDF content)
49
Sarkar S., Suresh M.R.An overview of tuberculosis chemotherapy – a literature review. J. Pharm. Pharm. Sci. 2011; 14 (2): 148–161. Информация об авторе Боровицкий Владислав Семенович– врач-фтизиатр учреждения
(check this in PDF content)